64 related articles for article (PubMed ID: 23161608)
1. Transcription factors link mouse WAP-T mammary tumors with human breast cancer.
Otto B; Streichert T; Wegwitz F; Gevensleben H; Klätschke K; Wagener C; Deppert W; Tolstonog GV
Int J Cancer; 2013 Mar; 132(6):1311-22. PubMed ID: 23161608
[TBL] [Abstract][Full Text] [Related]
2. Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression.
Otto B; Gruner K; Heinlein C; Wegwitz F; Nollau P; Ylstra B; Pantel K; Schumacher U; Baumbusch LO; Martin-Subero JI; Siebert R; Wagener C; Streichert T; Deppert W; Tolstonog GV
Int J Cancer; 2013 Mar; 132(6):1300-10. PubMed ID: 22907219
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
4. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
[TBL] [Abstract][Full Text] [Related]
6. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
7. Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography.
Jannasch K; Dullin C; Heinlein C; Krepulat F; Wegwitz F; Deppert W; Alves F
Int J Cancer; 2009 Jul; 125(1):62-70. PubMed ID: 19384954
[TBL] [Abstract][Full Text] [Related]
8. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
[TBL] [Abstract][Full Text] [Related]
9. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
10. Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.
Neumark E; Sagi-Assif O; Shalmon B; Ben-Baruch A; Witz IP
Int J Cancer; 2003 Oct; 106(6):879-86. PubMed ID: 12918065
[TBL] [Abstract][Full Text] [Related]
11. Loss of Stat5a delays mammary cancer progression in a mouse model.
Ren S; Cai HR; Li M; Furth PA
Oncogene; 2002 Jun; 21(27):4335-9. PubMed ID: 12082622
[TBL] [Abstract][Full Text] [Related]
12. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
13. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
14. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.
Krepulat F; Löhler J; Heinlein C; Hermannstädter A; Tolstonog GV; Deppert W
Oncogene; 2005 Jul; 24(29):4645-59. PubMed ID: 15870706
[TBL] [Abstract][Full Text] [Related]
16. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene.
Tzeng YJ; Guhl E; Graessmann M; Graessmann A
Oncogene; 1993 Jul; 8(7):1965-71. PubMed ID: 8390039
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
19. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.
Ponzo MG; Lesurf R; Petkiewicz S; O'Malley FP; Pinnaduwage D; Andrulis IL; Bull SB; Chughtai N; Zuo D; Souleimanova M; Germain D; Omeroglu A; Cardiff RD; Hallett M; Park M
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12903-8. PubMed ID: 19617568
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.
Coffelt SB; Chen YY; Muthana M; Welford AF; Tal AO; Scholz A; Plate KH; Reiss Y; Murdoch C; De Palma M; Lewis CE
J Immunol; 2011 Apr; 186(7):4183-90. PubMed ID: 21368233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
